HyperClear represents an innovative laser therapy system designed to effectively remove surplus prostatic tissue in benign prostatic hyperplasia (BPH). Leveraging the LIFE (Laser-Induced Fiber Enucleation) method, HyperClear applies precise laser energy via a flexible fiber placed transurethrally to the obstructive zone, ablating the excess prostate tissue responsible for lower urinary tract symptoms (LUTS). This approach may be performed outpatient—often with local anesthesia—enhancing patient comfort while maintaining efficacy and safety.
High-Precision Laser Fiber
- Optimized Energy Delivery: The laser fiber is advanced through the urethra to the blocked area, targeting surplus prostate tissue while minimizing collateral damage.
- LIFE Method: Focused on selective tissue vaporization or enucleation, ensuring clean resection planes and predictable tissue removal.
Outpatient Feasibility
- Local Anesthesia: Allows many patients to undergo the procedure without the risks or recovery times associated with general anesthesia.
- Rapid Recovery: Less invasive than conventional transurethral resections, potentially reducing hospital stays and improving patient throughput.
Real-Time Visualization
- Precise Tissue Identification: Endoscopic imaging guides the laser fiber to the obstructive tissue, ensuring thorough clearance of the prostatic urethra.
- Controlled Ablation: The surgeon can finely tune laser energy to match the tissue’s vascularity and density, limiting the risk of deep thermal damage.
Efficient & Gentle Tissue Removal
- Targeted Laser Ablation: Precisely removes hyperplastic prostate segments that hinder urine flow, preserving healthy tissue zones.
- Hemostatic Effect: Laser energy also cauterizes small vessels during tissue vaporization, reducing intraoperative bleeding.
临床优势与应用
Benign Prostatic Hyperplasia (BPH)
- Symptomatic Relief: Alleviates classic LUTS such as frequent urination, weak urine stream, and prolonged emptying times.
- Patient Selection: Suited for patients with moderate-to-severe BPH who seek a less invasive alternative to standard TURP or open prostatectomy.
Minimal Invasiveness
- Outpatient Possibility: Potentially performed under local anesthesia, minimizing hospitalization and facilitating early mobilization.
- Lower Bleeding Risk: Laser-based enucleation or vaporization significantly reduces hemorrhage compared to mechanical resection methods.
改善患者体验
- Shorter Convalescence: Many patients resume daily activities sooner, with less postoperative discomfort or catheterization durations.
- Reduced Need for General Anesthesia: Local or spinal anesthesia lessens systemic risks, beneficial for older or comorbid patients.
Technical Specifications
规格 | 细节/价值 |
产品名称 | CytroFIX® Superior Clavicula 菌落总数计数板 |
材料 | High-Purity Titanium Alloy (e.g., Ti-6Al-4V ELI) |
Plate Profile | Low-profile, contoured for superior clavicle placement |
Locking Mechanism | Locking or non-locking titanium screws; optional variable-angle locking |
Screw Diameter | 2.7 mm or 3.5 mm (titanium cortical screws, depending on hole specification) |
Plate Thickness | ~2.0–2.5 mm (minimized profile) |
Hole Array | Multiple holes for bridging, compression, or combined fixation patterns |
辐射能力 | Titanium visible on fluoroscopy (optional etched markers) |
无菌 | Provided non-sterile (autoclavable) or sterile, single use or reusable instrumentation (verify product line) |
保质期 | Indefinite if stored properly; reusable within recommended inspection cycles |
临床适应症 | Midshaft/lateral clavicle fractures requiring superior plating, osteotomies, nonunion correction |
Regulatory Compliance | Conforms to ISO 13485, CE/FDA (region-specific), meets orthopedic implant standards |
Size & Ordering Matrix
Plate Length (mm) | Hole Count | Curvature | Compatible Screw | 产品代码 | 说明 |
60 | 4 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-60-4-27-Ti | Shorter plate for smaller fractures in lateral or mid-shaft |
70 | 5 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-70-5-27-Ti | Extended coverage for mild to moderate fractures |
80 | 5 | Moderate Superior Bend | 2.7 or 3.5 mm Locking | CFX-SCL-80-5-MX-Ti | Bridges midshaft fractures with variable-angle options |
90 | 6 | Moderate Superior Bend | 3.5 mm Locking/Non-Locking | CFX-SCL-90-6-35-Ti | For larger or multi-fragment fractures requiring robust support |
100 | 7 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-100-7-35-Ti | Accommodates more complex or extended fracture lines |
110 | 8 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-110-8-35-Ti | Longest plate design for challenging multi-segment fractures |
相关产品
-
Atlas 不锈钢冠状动脉支架系统
阅读更多A 不锈钢 提供冠状动脉支架 坚固 结构完整性和 轻松 为常规经皮冠状动脉介入治疗(PCI)提供可送达性,兼顾成本效益和可靠性能。
-
Extender 紫杉醇药物洗脱 PTCA 球囊导管
阅读更多A 紫杉醇涂层 冠状动脉球囊导管,旨在 减少再狭窄 在经皮冠状动脉腔内成形术(PTCA)期间,确保向血管壁有效输送药物。
-
ArthroXis 关节镜综合系统
阅读更多高度先进的系统,专为微创关节手术而设计,结合了精确的可视化和手术工具,可提高关节镜手术的准确性、效率和患者恢复能力
-
Bionovus 肾切除术经皮肾造瘘导管(尾纤)
阅读更多精确设计的尾纤导管专为经皮肾造瘘术量身定制,可确保在肾切除术和相关手术中安全放置、高效引流并减少患者不适。